Pharmaceutical
India pharmaceutical industry has established itself as a prominent player on the worldwide stage for research and innovation, thanks to a solid foundation in science and technology, increasing government backing, a thriving local market, and affordable manufacturing processes.
Schedule a Call Back
Businesses we've worked with in the pharmaceutical industry
Showing 311 clients- Clients include
- Eli Lilly and Company (India) · Mankind Pharma · Beryl Drugs · Rajasthan Antibiotics · G D Pharmaceuticals · Micro Labs · Anglo French Drug and Industries · Winbioz Pharma · Zseps Pharmaceuticals · Cipla · Tablets (India)Limited · +8 more
Pvt.Ltd.webp&w=256&q=75 "SMC Corporation (India) Pvt Ltd"){kind=small}
Industries
Recycling & Waste Management
Recycling is an essential part of waste management. It helps to conserve natural resources, reduce landfill waste, conserve energy, and crea...
KNOW MORE ›Trading Business
Trade of a business reflects the value of services exchanged between domestic and foreign economic members, including the value of services ...
KNOW MORE ›Chemicals
There has been a global shift towards Asia as the world’s chemical manufacturing hub lately. The future of the chemical industry in India de...
KNOW MORE ›How to Setup Pharmaceutical Industry in India
The pharmaceutical industry in India is a vital sector that significantly contributes to both the national economy and global healthcare. Renowned for its cost-effective manufacturing and substantial production capabilities, India is a leading provider of generic drugs, supplying over 20% of the global market. The industry is valued at around USD 42 billion as of 2023, with projections indicating it will grow to USD 65 billion by 2024.
The Pharmaceutical Industry Does Not Cure, It Creates Customers
The industry added almost 1.32% to the Gross Value Added in the Indian Economy for the year 2020-21. The Pharmaceuticals sector had a total annual revenue of $42.34 billion in fiscal year 2021-22. Primary sectors of the Indian Pharmaceutical Industry comprise generic drugs, over-the-counter medicines, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics.
The Vision Pharma 2047: By the year 2047, the Government aims to accomplish the following goals:
- Make India a global leader in the manufacturing of affordable, innovative & quality pharmaceuticals & medical devices for the goal of Vasudhaiva kutumbakam
- Vishwaguru in innovation & Research for delivering healthcare products to future generations in a sustainable manner, Introduction of natural products.
- Ensure accessibility & affordability of patient-centric products for better healthcare outcomes for universal health coverage by building upon partnerships across industry, science, and government
- Contribute to the Health Systems to attain a union of equity, efficacy, and efficiency toward developing a holistic product profile focusing on NCDs, AMR, and rare & neglected diseases.
- Create Equilibrium between social, economic & governance aspects through facilitative, balanced & progressive policy and regulatory framework
- Reduce India’s Carbon footprint in Pharma-Med Tech to align with the Hon’ble PM’s vision for Panchamrita
- Identifying critical suppliers, de-risking & decarbonizing the supply chain, and promoting local sourcing
- Medical devices are essential components of worldwide supply chains, including raw materials, components, spare parts, assemblies, and subassemblies.
- Digitalization and technology upgradation in the delivery of services & products under Jan Aushadhi Pariyojana
India's government is taking a multifaceted approach, engaging industry and academia, developing infrastructure, and more to boost research and innovation in the pharmaceutical sector. The policies mentioned above are helping to create an environment that is conducive to innovation in the pharmaceutical sector.
India's pharmaceutical industry is in a prime position to maintain its leading role in research and innovation in the future. The nation's robust scientific and technological foundation, increasing government backing, and expansive local market will continue to fuel innovation. In addition, India’s cost-competitive manufacturing capabilities will make it an attractive location for global pharmaceutical companies to conduct R&D
The pharmaceutical industry in India is a significant sector, contributing to both the domestic economy and the global healthcare market. Known for its robust production capabilities and cost-effective manufacturing, the Indian pharmaceutical industry holds a prominent position globally
Market Size and Growth of Pharmaceutical Industry
- As of 2023, the Indian pharmaceutical market is valued at around USD 42 billion and is projected to grow to USD 65 billion by 2024.
- The industry is experiencing a CAGR (Compound Annual Growth Rate) of about 10-12%.
Global Standing
- India is the largest provider of generic drugs globally, supplying over 20% of the global generic drug market.
- The country is also a major supplier of vaccines, accounting for over 50% of global vaccine demand.
Key Segments of Pharmaceutical Industry in India
Active Pharmaceutical Ingredients (APIs):
- India is one of the leading producers of APIs, supplying to both domestic and international markets.
- Efforts are being made to reduce dependency on imports, particularly from China, through government initiatives like the Production Linked Incentive (PLI) Scheme.
Formulations:
- The formulations segment involves the production of finished dosage forms like tablets, capsules, and injectables.
- Indian companies are known for their high-quality generic formulations, which are exported to over 200 countries.
Biotechnology:
- The biotech sector in India is growing rapidly, focusing on biopharmaceuticals, biosimilars, and bio-services.
- India is home to several leading biotech companies that are making significant advancements in drug discovery and development.
Contract Research and Manufacturing Services (CRAMS):
- India has emerged as a preferred destination for CRAMS due to its skilled workforce, cost advantages, and strong regulatory framework.
- The country offers a range of services including clinical trials, contract manufacturing, and drug development.
Regulatory Framework of Pharmaceutical Sector in India
Central Drugs Standard Control Organization (CDSCO):
- CDSCO, under the Ministry of Health and Family Welfare, is the primary regulatory body responsible for drug approval and quality control.
- The Drug Controller General of India (DCGI) oversees the implementation of various regulations.
Good Manufacturing Practices (GMP):
- Indian pharmaceutical companies adhere to GMP guidelines, ensuring high standards of production and quality control.
Challenges Of Pharmaceutical Industry In India
Regulatory Compliance:
- Maintaining compliance with both domestic and international regulations is a significant challenge.
- Regular audits and stringent quality checks are necessary to meet global standards.
Quality Control:
- Ensuring consistent quality in manufacturing processes is critical to maintaining the reputation of Indian pharmaceuticals.
Supply Chain Disruptions:
- The industry faces challenges related to raw material shortages and supply chain disruptions, particularly highlighted during the COVID-19 pandemic.
Government Initiatives of Pharmaceutical Industry in India
Production Linked Incentive (PLI) Scheme:
Aimed at boosting domestic manufacturing and reducing import dependency, the PLI scheme offers financial incentives for production and R&D.
Atmanirbhar Bharat:
The self-reliant India initiative encourages local production of APIs and intermediates to strengthen the domestic pharmaceutical industry.
Future of Pharmaceutical Industry in India
Innovation and R&D:
Increased investment in R&D is expected to drive innovation, with a focus on new drug development, biosimilars, and biotechnology.
Market Expansion:
Indian pharmaceutical companies are exploring new markets and expanding their global footprint, particularly in emerging economies.
Digital Transformation:
Adoption of digital technologies, such as AI and big data analytics, is set to revolutionize drug discovery, manufacturing, and distribution processes.
The Indian pharmaceutical industry is poised for significant growth, driven by its cost-effective manufacturing, robust R&D capabilities, and supportive government policies. As it continues to evolve, the industry is expected to play an increasingly indispensable role in global healthcare.
Why Corpseed?
Corpseed’s comprehensive services help pharmaceutical companies navigate the complex regulatory landscape, achieve compliance, and capitalize on growth opportunities. By offering expert guidance and support, Corpseed ensures that pharmaceutical businesses can focus on innovation and delivering quality healthcare products to the market.
Enquiry Now
Pharmaceutical
Enquiry Now
Pharmaceutical
Industries We Cater To
Manufacturing
The manufacturing industry comprises businesses engaged in producing tangible goods Advances in automation, collaboration, innovation, and other areas also contribute to improving manufacturing quality and efficiency using AI and machine learning.
KNOW MOREFrequently Asked Questions
Quick answers to common questions about this service.
What can be the present size of the Indian pharmaceutical industry?
The Indian pharmaceuticals industry is now about USD 42 billion and is headed to become a USD 65 billion sector by 2024. It forms one of the largest and fastest-growing sectors in the country.
Which are the main segments of the Indian pharmaceutical industry?
These various segments of the industry may be segregated as bulk drugs, formulations, biotechnology, and contract research and manufacturing services.
What is the ranking or position of India in pharmaceutical production globally?
India is the biggest exporter of generic drugs with a 20 percent share of the global export volume and a significant supplier of vaccines to the international market, accounting for above 50 percent of global requirements.
What are the key regulatory authorities of the pharmaceutical industry in India?
The major regulating authorities are the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare, and the Drug Controller General of India (DCGI).
Which are the major challenges that the pharmaceutical industry is facing in India?
Industry challenges include regulatory compliance, quality control, supply chain disruptions, intellectual property issues, and increased competition from other emerging markets.
What are some of the initiatives of the government extended to the pharmaceutical industry in India?
The Government of India has come up with various initiatives, including the Production Linked Incentive Scheme for Pharmaceuticals, which is oriented toward improving the capability of local production with a view to enhancing output and exports.
How does the pharmaceutical industry in India contribute to global healthcare?
India caters to more than 200 countries with its competitively priced generic medicines, consequently contributing massively towards the world's healthcare by considerably cutting down the cost of treatment for many diseases, including HIV/ AIDS, malaria, and tuberculosis.
What position does R&D hold in the Indian pharmaceutical industry?
R&D holds a central place in the development of the pharmaceutical industry. Indian companies are investing more and more in R&D to invent new drugs and enhance existing formulations to world standard norms.
What is the role or importance of the Active Pharmaceutical Ingredient sector in India?
APIs are the heart of any drug. India is one of the largest API manufacturers. These products are utilized in formulating generic and branded drugs. Under the Atmanirbhar Bharat initiative, the country targets reducing dependency on key starting material imports and intermediates.
How has the COVID-19 pandemic affected the Pharmaceutical Industry in India?
The pandemic has accelerated the demand for medicines and vaccines while underscoring India's place as a global supplier. It has also acted as an impetus to the industry, further pushing innovation, hastening treatments, and developing vaccines.